Forskolin Derivatives. I. Synthesis, and Cardiovascular and Adenylate Cyclase-Stimulating Activities of Water-Soluble Forskolins
スポンサーリンク
概要
- 論文の詳細を見る
Water-soluble forskolin and 7-deacetylforskolin derivatives with an aminoacetyl, a 3-aminopropionyl, or a 4-aminobutyryl group at the 6- or 7-position were prepared, and their positive inotropic as well as vasodilative activities were evaluated in anesthetized dogs.7-Deacetylforskolin (2) and 7-deacetyl-1-silylforskolin (6) were converted to the corresponding 7-chloroacylderivatives (3,7,10), which were reacted with amines to obtain 7-aminoacyl-7-deacetylforskolins (4a-f, 9a, b, 11). The 7-acyl substituents migrated to the 6-position with sodium hydroxide in acetonitrile-water to afford 6-aminoacyl-7-deacetylforskolins (12a-f). The 7-position of 12a, d-f was selectively acetylated with acetyl chloride to obtain the corresponding 6-aminoacylforskolins (13a-d).Among the 6-aminoacylforskolins, 6-(3-dimethylaminopropionyl)forskolin (13b) and 6-(4-dimethylaminobutyryl)forskolin (13d) exhibited potent positive inotropic and vasodilative activities comparable to those of forskolin (1).The activities of 13b and 13d were approximately ten times more potent than those of 7-aminoacyl- and 6-aminoacyl-7-deacetylforskolins (4a-f, 9a, 12a-c, f). 6-Dimethylaminoacetylforskolin (13a) and 6-(3-diethylaminopropionyl)forskolin (13c) were less potent than 1. The effects of the soluble forskolins on adenylate cyclase activity were also examined in vitro. 6-Aminoacylforskolins (13a-d) exhibited potent adenylate cyclase-stimulating activity, comparable to that of 1.
- 社団法人日本薬学会の論文
- 1996-12-15
著者
-
Hosono M
Research And Development Division Pharmaceuticals Group Nippon Kayaku Co. Ltd.
-
TATEE Tochiro
Research and Development Division, Pharmaceuticals Group, Nippon Kayaku Co., Ltd.,
-
NARITA Aya
Research and Development Division, Pharmaceuticals Group, Nippon Kayaku Co., Ltd.,
-
NARITA Kazuhisa
Research and Development Division, Pharmaceuticals Group, Nippon Kayaku Co., Ltd.,
-
IZUMI Giichi
Research and Development Division, Pharmaceuticals Group, Nippon Kayaku Co., Ltd.,
-
TAKAHIRA Takashi
Research and Development Division, Pharmaceuticals Group, Nippon Kayaku Co., Ltd.,
-
SAKURAI Masao
Research and Development Division, Pharmaceuticals Group, Nippon Kayaku Co., Ltd.,
-
FUJITA Akira
Research and Development Division, Pharmaceuticals Group, Nippon Kayaku Co., Ltd.,
-
HOSONO Makoto
Research and Development Division, Pharmaceuticals Group, Nippon Kayaku Co., Ltd.,
-
YAMASHITA Kouwa
Research and Development Division, Pharmaceuticals Group, Nippon Kayaku Co., Ltd.,
-
ENOMOTO Keiko
Research and Development Division, Pharmaceuticals Group, Nippon Kayaku Co., Ltd.,
-
SHIOZAWA Akira
Research and Development Division, Pharmaceuticals Group, Nippon Kayaku Co., Ltd.,
-
Narita Aya
Research And Development Division Pharmaceuticals Group Nippon Kayaku Co. Ltd.
-
Izumi Giichi
Research And Development Division Pharmaceuticals Group Nippon Kayaku Co. Ltd.
-
Tatee T
Research And Development Division Pharmaceuticals Group Nippon Kayaku Co. Ltd.
-
Enomoto Keiko
Research And Development Division Pharmaceuticals Group Nippon Kayaku Co. Ltd.
-
Hosono Makoto
Research And Development Division Pharmaceuticals Group Nippon Kayaku Co. Ltd
-
Sakurai M
Research And Development Division Pharmaceuticals Group Nippon Kayaku Co. Ltd.
-
Shiozawa A
Research And Development Division Pharmaceuticals Group Nippon Kayaku Co. Ltd.
-
Sakurai Masao
Research And Development Division Pharmaceuticals Group Nippon Kayaku Co. Ltd.
-
Narita Kazuhisa
Research And Development Division Pharmaceuticals Group Nippon Kayaku Co. Ltd.
-
Yamashita Kouwa
Research And Development Division Pharmaceuticals Group Nippon Kayaku Co. Ltd.
-
Takahira Takashi
Research And Development Division Pharmaceuticals Group Nippon Kayaku Co. Ltd.
-
Shiozawa Akira
Research And Development Division Pharmaceuticals Group Nippon Kayaku Co. Ltd.
-
Fujita A
Research And Development Division Pharmaceuticals Group Nippon Kayaku Co. Ltd.
関連論文
- Forskolin Derivatives. I. Synthesis, and Cardiovascular and Adenylate Cyclase-Stimulating Activities of Water-Soluble Forskolins
- Isoxazole Derivatives as Centrally Acting Muscle Relaxants. III. : Synthesis and Activity of Conformationally Restricted Analogs(Medeicinal Chemistry,Chemical)
- Bronchodilator and Cardiovascular Effects of NKH477, a Novel Water-Soluble Forskolin Derivative, in Guinea Pigs
- MICRODETERMINATION OF PROSTAGLANDINS AND THROMBOXANE B_2 BY GAS CHROMATOGRPHY/HIGH RESOLUTION-SELECTED ION MONITORING
- STUDIES ON METABOLISM OF NK422 BY GAS CHROMATOGRAPHY-ELECTRON IMPACT-MASS SPECTROMETRY AND FAST ATOM BOMBARDMENT-MASS SPECTROMETRY
- Microdetermination of 11-Dehydro-TXB_2 in Human Urine by Gas Chromatography/Selected Ion Monitoring
- QUANTITATION OF PROSTAGLANDINS BY GAS CHROMATOGRAPHY-METASTABLE ION MONITORING
- Measurement of the novel decapeptide cetrorelix in human plasma and urine by liquid chromatography-electrospray ionization mass spectrometry
- Improvement of Drug-Induced Cardiac Failure by NKH477, a Novel Forskolin Derivative, in the Dog Heart-Lung Preparation.